Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther W Chan

Showing results (71-80 of 175) with videos related to

Pageof 18
Sort By:
BMC Pulmonary Medicine|May 14, 2024
SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese populationLydia Wy Fung, Vincent Kc Yan, Christine Kwan, et al.
Plos One|March 25, 2016
Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke IncidencePak Hei Chan, Jo Jo Hai, Esther W Chan, et al.
Journal of the American Medical Directors Association|November 3, 2015
Prescribed Doses of Opioids in Long-Term Care FacilitiesBrian Leung, Natali Jokanovic, Edwin C K Tan, et al.
Thrombosis Research|April 28, 2018
Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016Duo Huang, Pak-Hei Chan, Hoi-Lam She, et al.
The Canadian Journal of Cardiology|March 2, 2016
Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial FibrillationPak-Hei Chan, Wen-Hua Li, Jo-Jo Hai, et al.
Drug Safety|June 20, 2020
Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort StudyXue Li, Swathi Pathadka, Kenneth K C Man, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2017
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groupsKim S J Lao, Anthony W Y Tam, Ian C K Wong, et al.
CNS Drugs|December 20, 2017
Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational StudiesKenneth K C Man, Patrick Ip, Esther W Chan, et al.
BJGP Open|April 22, 2026
Potential interactions between SSRIs and DOACs: population-based cohort and case-crossover studyMarco Chau, Charlotte Warren-Gash, Krishnan Bhaskaran, et al.
Heart Rhythm|April 2, 2016
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort studyEsther W Chan, Wallis C Y Lau, Chung Wah Siu, et al.
Pageof 18

Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
BMC Pulmonary Medicine|May 14, 2024
SABINA + Hong Kong: a territory wide study of prescribing trends and outcomes associated with the use of short-acting β2 agonists in the Chinese populationLydia Wy Fung, Vincent Kc Yan, Christine Kwan, et al.
Plos One|March 25, 2016
Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke IncidencePak Hei Chan, Jo Jo Hai, Esther W Chan, et al.
Journal of the American Medical Directors Association|November 3, 2015
Prescribed Doses of Opioids in Long-Term Care FacilitiesBrian Leung, Natali Jokanovic, Edwin C K Tan, et al.
Thrombosis Research|April 28, 2018
Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016Duo Huang, Pak-Hei Chan, Hoi-Lam She, et al.
The Canadian Journal of Cardiology|March 2, 2016
Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial FibrillationPak-Hei Chan, Wen-Hua Li, Jo-Jo Hai, et al.
Drug Safety|June 20, 2020
Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort StudyXue Li, Swathi Pathadka, Kenneth K C Man, et al.
Pharmacoepidemiology and Drug Safety|July 1, 2017
Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groupsKim S J Lao, Anthony W Y Tam, Ian C K Wong, et al.
CNS Drugs|December 20, 2017
Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational StudiesKenneth K C Man, Patrick Ip, Esther W Chan, et al.
BJGP Open|April 22, 2026
Potential interactions between SSRIs and DOACs: population-based cohort and case-crossover studyMarco Chau, Charlotte Warren-Gash, Krishnan Bhaskaran, et al.
Heart Rhythm|April 2, 2016
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort studyEsther W Chan, Wallis C Y Lau, Chung Wah Siu, et al.
Pageof 18